Expanding phenotype with severe midline brain anomalies and missense variant supports a causal role for FOXA2 in 20p11.2 deletion syndrome.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
09 2019
Historique:
received: 03 12 2018
revised: 30 04 2019
accepted: 05 06 2019
pubmed: 12 7 2019
medline: 4 8 2020
entrez: 12 7 2019
Statut: ppublish

Résumé

Rare individuals with 20p11.2 proximal deletions have been previously reported, with a variable phenotype that includes heterotaxy, biliary atresia, midline brain defects associated with panhypopituitarism, intellectual disability, scoliosis, and seizures. Deletions have ranged in size from 277 kb to 11.96 Mb. We describe a newborn with a de novo 2.7 Mb deletion of 20p11.22p11.21 that partially overlaps previously reported deletions and encompasses FOXA2. Her clinical findings further expand the 20p11.2 deletion phenotype to include severe midline cranial and intracranial defects such as aqueductal stenosis with hydrocephalus, mesencephalosynapsis with diencephalic-mesencephalic junction dysplasia, and pyriform aperture stenosis. We also report one individual with a missense variant in FOXA2 who had abnormal glucose homeostasis, panhypopituitarism, and endodermal organ dysfunction. Together, these findings support the critical role of FOXA2 in panhypopituitarism and midline defects.

Identifiants

pubmed: 31294511
doi: 10.1002/ajmg.a.61281
doi:

Substances chimiques

FOXA2 protein, human 0
Hepatocyte Nuclear Factor 3-beta 135845-92-0

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1783-1790

Subventions

Organisme : NICHD NIH HHS
ID : U54 HD083091
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Jennifer N Dines (JN)

Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington.
Department of Pediatrics, Division of Genetic Medicine, University of Washington/Seattle Children's Hospital, Seattle, Washington.

Yajuan J Liu (YJ)

Department of Pathology, University of Washington School of Medicine, Seattle, Washington.

Whitney Neufeld-Kaiser (W)

Department of Pathology, University of Washington School of Medicine, Seattle, Washington.

Taylor Sawyer (T)

Department of Pediatrics, Division of Neonatology, University of Washington, Seattle, Washington.

Gisele E Ishak (GE)

Department of Radiology, University of Washington, Seattle Children's Hospital, Seattle, Washington.

Hannah M Tully (HM)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington.
Division of Pediatric Neurology, Seattle Children's Hospital, Seattle, Washington.

Melissa Racobaldo (M)

Division of Genetics and Metabolism, University of South Florida, Tampa, Florida.

Amarilis Sanchez-Valle (A)

Division of Genetics and Metabolism, University of South Florida, Tampa, Florida.

Christine M Disteche (CM)

Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington.
Department of Pathology, University of Washington School of Medicine, Seattle, Washington.

Jane Juusola (J)

GeneDx, Inc., Gaithersburg, Maryland.

Erin Torti (E)

GeneDx, Inc., Gaithersburg, Maryland.

Kirsty McWalter (K)

GeneDx, Inc., Gaithersburg, Maryland.

Dan Doherty (D)

Department of Pediatrics, Division of Genetic Medicine, University of Washington/Seattle Children's Hospital, Seattle, Washington.
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington.

Katrina M Dipple (KM)

Department of Pediatrics, Division of Genetic Medicine, University of Washington/Seattle Children's Hospital, Seattle, Washington.
Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH